Viral Hepatitis News Roundup for World Hepatitis Day

Content From: HIV.govPublished: July 31, 20192 min read


World Hepatitis Day logo - made up of a globe shaped with translations of "This is hepatitis"
Credit: World Hepatitis Alliance

World Hepatitis Day was observed earlier this week, July 28. So we wanted to share several recent blog posts from our colleagues at the HHS viral hepatitis blog that may be of interest to our readers, too, given the shared routes of transmission of HIV and viral hepatitis, overlaps in populations most affected, and high rates of coinfection among people living with HIV.

World Hepatitis Day: Working Toward Elimination

Corinna Dan, Viral Hepatitis Policy Advisor at the HHS Office of Infectious Disease and HIV/AIDS Policy, highlights and celebrates the growing number of hepatitis elimination projects being established across the United States. Read the post.

Recent Hepatitis A Outbreaks Occurring in Gay and Bisexual Men

Ms. Dan discusses the outbreaks, provides a brief overview of hepatitis A, explains that hepatitis A can be prevented with a safe and effective vaccine, and encourages gay men to get vaccinated. Get informed.

Curing Hepatitis C in People Living with HIV in the United States: A Federal, State and Local Collaboration

The AIDS Education and Training Centers program shared this post highlighting the evolution of the Ryan White HIV/AIDS Program’s HIV/HCV coinfection project from curriculum development through training implementation and resource development. Learn more about these resources.

Through Strategic Action, the Ryan White HIV/AIDS Program Can Move the U.S. Toward Elimination of Hepatitis C among People with HIV

A brief from Georgetown Law’s O’Neill Institute describes the role of this HRSA program in eliminating HCV among people with HIV. Dig deeper.

Efforts are underway to develop the next iteration of the National Viral Hepatitis Strategy in parallel to efforts to develop the next iteration of the National HIV/AIDS Strategy.

Learn more about hepatitis B and C and people with HIV.